Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Sjögren M[au]:

[Body dysmorphic disorder]. Jawad MB et al. Ugeskr Laeger. (2017)

The future of blood-based biomarkers for Alzheimer's disease. Henriksen K et al. Alzheimers Dement. (2014)

A systematic review of blood-based serotonergic biomarkers in Bulimia Nervosa. Sjögren M et al. Psychiatry Res. (2018)

Search results

Items: 1 to 50 of 248

1.

[Bilateral stress fractures of the pelvic rami in a woman with anorexia nervosa].

Bashir K, Sjögren M, Klit J.

Ugeskr Laeger. 2019 Mar 18;181(12). pii: V10180702. Danish.

PMID:
30931885
2.

A systematic review of blood-based serotonergic biomarkers in Bulimia Nervosa.

Sjögren M, Nielsen ASM, Hasselbalch KC, Wøllo M, Hansen JS.

Psychiatry Res. 2018 Dec 31. pii: S0165-1781(18)31579-8. doi: 10.1016/j.psychres.2018.12.167. [Epub ahead of print] Review.

PMID:
30878305
3.

Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes.

Gusarova V, O'Dushlaine C, Teslovich TM, Benotti PN, Mirshahi T, Gottesman O, Van Hout CV, Murray MF, Mahajan A, Nielsen JB, Fritsche L, Wulff AB, Gudbjartsson DF, Sjögren M, Emdin CA, Scott RA, Lee WJ, Small A, Kwee LC, Dwivedi OP, Prasad RB, Bruse S, Lopez AE, Penn J, Marcketta A, Leader JB, Still CD, Kirchner HL, Mirshahi UL, Wardeh AH, Hartle CM, Habegger L, Fetterolf SN, Tusie-Luna T, Morris AP, Holm H, Steinthorsdottir V, Sulem P, Thorsteinsdottir U, Rotter JI, Chuang LM, Damrauer S, Birtwell D, Brummett CM, Khera AV, Natarajan P, Orho-Melander M, Flannick J, Lotta LA, Willer CJ, Holmen OL, Ritchie MD, Ledbetter DH, Murphy AJ, Borecki IB, Reid JG, Overton JD, Hansson O, Groop L, Shah SH, Kraus WE, Rader DJ, Chen YI, Hveem K, Wareham NJ, Kathiresan S, Melander O, Stefansson K, Nordestgaard BG, Tybjærg-Hansen A, Abecasis GR, Altshuler D, Florez JC, Boehnke M, McCarthy MI, Yancopoulos GD, Carey DJ, Shuldiner AR, Baras A, Dewey FE, Gromada J.

Nat Commun. 2018 Jun 13;9(1):2252. doi: 10.1038/s41467-018-04611-z.

4.

Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntington's Disease.

Duarte AI, Sjögren M, Santos MS, Oliveira CR, Moreira PI, Björkqvist M.

Sci Rep. 2018 Jun 12;8(1):8961. doi: 10.1038/s41598-018-27121-w.

5.

Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barré syndrome: A pilot study.

Axelsson M, Sjögren M, Andersen O, Blennow K, Zetterberg H, Lycke J.

Acta Neurol Scand. 2018 Aug;138(2):143-150. doi: 10.1111/ane.12927. Epub 2018 Apr 6.

PMID:
29624650
6.

A systematic review of studies on the faecal microbiota in anorexia nervosa: future research may need to include microbiota from the small intestine.

Schwensen HF, Kan C, Treasure J, Høiby N, Sjögren M.

Eat Weight Disord. 2018 Aug;23(4):399-418. doi: 10.1007/s40519-018-0499-9. Epub 2018 Mar 14. Review.

PMID:
29542066
7.

Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease R6/2 mice.

Soylu-Kucharz R, Sandelius Å, Sjögren M, Blennow K, Wild EJ, Zetterberg H, Björkqvist M.

Sci Rep. 2017 Oct 26;7(1):14114. doi: 10.1038/s41598-017-14179-1.

8.

Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington's disease.

Sjögren M, Duarte AI, McCourt AC, Shcherbina L, Wierup N, Björkqvist M.

Sci Rep. 2017 Oct 24;7(1):13896. doi: 10.1038/s41598-017-13713-5.

9.

Genetic risk factors influence nighttime blood pressure and related cardiovascular complications in patients with coronary heart disease.

Wirtwein M, Melander O, Sjőgren M, Hoffmann M, Narkiewicz K, Gruchala M, Sobiczewski W.

Hypertens Res. 2018 Jan;41(1):53-59. doi: 10.1038/hr.2017.87. Epub 2017 Oct 5.

PMID:
28978984
10.

[Body dysmorphic disorder].

Jawad MB, Sjögren M.

Ugeskr Laeger. 2017 Feb 6;179(6). pii: V08160556. Review. Danish.

PMID:
28397684
11.

Elevated ambulatory systolic-diastolic pressure regression index is genetically determined in hypertensive patients with coronary heart disease.

Wirtwein M, Melander O, Sjőgren M, Hoffmann M, Narkiewicz K, Gruchala M, Sobiczewski W.

Blood Press. 2017 Jun;26(3):174-180. doi: 10.1080/08037051.2016.1273741. Epub 2017 Jan 16.

PMID:
28092973
12.

Hepatitis C eradication with sofosbuvir leads to significant metabolic changes.

Morales AL, Junga Z, Singla MB, Sjogren M, Torres D.

World J Hepatol. 2016 Dec 18;8(35):1557-1563. doi: 10.4254/wjh.v8.i35.1557.

13.

Relationship between selected DNA polymorphisms and coronary artery disease complications.

Wirtwein M, Melander O, Sjőgren M, Hoffmann M, Narkiewicz K, Gruchala M, Sobiczewski W.

Int J Cardiol. 2017 Feb 1;228:814-820. doi: 10.1016/j.ijcard.2016.11.060. Epub 2016 Nov 9.

PMID:
27888760
14.

The Relationship Between Gene Polymorphisms and Dipping Profile in Patients With Coronary Heart Disease.

Wirtwein M, Melander O, Sjőgren M, Hoffmann M, Narkiewicz K, Gruchala M, Sobiczewski W.

Am J Hypertens. 2016 Sep;29(9):1094-102. doi: 10.1093/ajh/hpw040. Epub 2016 May 17.

PMID:
27189819
15.

Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure.

Smith JG, Felix JF, Morrison AC, Kalogeropoulos A, Trompet S, Wilk JB, Gidlöf O, Wang X, Morley M, Mendelson M, Joehanes R, Ligthart S, Shan X, Bis JC, Wang YA, Sjögren M, Ngwa J, Brandimarto J, Stott DJ, Aguilar D, Rice KM, Sesso HD, Demissie S, Buckley BM, Taylor KD, Ford I, Yao C, Liu C; CHARGE-SCD consortium; EchoGen consortium; QT-IGC consortium; CHARGE-QRS consortium, Sotoodehnia N, van der Harst P, Stricker BH, Kritchevsky SB, Liu Y, Gaziano JM, Hofman A, Moravec CS, Uitterlinden AG, Kellis M, van Meurs JB, Margulies KB, Dehghan A, Levy D, Olde B, Psaty BM, Cupples LA, Jukema JW, Djousse L, Franco OH, Boerwinkle E, Boyer LA, Newton-Cheh C, Butler J, Vasan RS, Cappola TP, Smith NL.

PLoS Genet. 2016 May 5;12(5):e1006034. doi: 10.1371/journal.pgen.1006034. eCollection 2016 May.

16.

Gene variance in the nicotinic receptor cluster (CHRNA5-CHRNA3-CHRNB4) predicts death from cardiopulmonary disease and cancer in smokers.

Halldén S, Sjögren M, Hedblad B, Engström G, Hamrefors V, Manjer J, Melander O.

J Intern Med. 2016 Apr;279(4):388-98. doi: 10.1111/joim.12454. Epub 2015 Dec 22.

17.

Genetic vasopressin 1b receptor variance in overweight and diabetes mellitus.

Enhörning S, Sjögren M, Hedblad B, Nilsson PM, Struck J, Melander O.

Eur J Endocrinol. 2016 Jan;174(1):69-75. doi: 10.1530/EJE-15-0781. Epub 2015 Oct 26.

18.

An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter.

Lucey BP, Gonzales C, Das U, Li J, Siemers ER, Slemmon JR, Bateman RJ, Huang Y, Fox GB, Claassen JA, Slats D, Verbeek MM, Tong G, Soares H, Savage MJ, Kennedy M, Forman M, Sjögren M, Margolin R, Chen X, Farlow MR, Dean RA, Waring JF.

Alzheimers Res Ther. 2015 Jul 29;7(1):53. doi: 10.1186/s13195-015-0136-z. eCollection 2015.

19.

Affinity states of biocides determine bioavailability and release rates in marine paints.

Dahlström M, Sjögren M, Jonsson PR, Göransson U, Lindh L, Arnebrant T, Pinori E, Elwing H, Berglin M.

Biofouling. 2015;31(2):201-10. doi: 10.1080/08927014.2015.1012639.

PMID:
25775096
20.

Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations.

Marwa KJ, Schmidt T, Sjögren M, Minzi OM, Kamugisha E, Swedberg G.

Malar J. 2014 Nov 3;13:420. doi: 10.1186/1475-2875-13-420.

21.

A genetic risk score for hypertension associates with the risk of ischemic stroke in a Swedish case-control study.

Fava C, Sjögren M, Olsson S, Lövkvist H, Jood K, Engström G, Hedblad B, Norrving B, Jern C, Lindgren A, Melander O.

Eur J Hum Genet. 2015 Jul;23(7):969-74. doi: 10.1038/ejhg.2014.212. Epub 2014 Oct 8.

22.

Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke.

Tada H, Shiffman D, Smith JG, Sjögren M, Lubitz SA, Ellinor PT, Louie JZ, Catanese JJ, Engström G, Devlin JJ, Kathiresan S, Melander O.

Stroke. 2014 Oct;45(10):2856-2862. doi: 10.1161/STROKEAHA.114.006072. Epub 2014 Aug 14.

23.

Effect of diagnostic criteria on prevalence of frontotemporal dementia in the elderly.

Gislason TB, Östling S, Börjesson-Hanson A, Sjögren M, Simoni M, Pantoni L, Skoog I.

Alzheimers Dement. 2015 Apr;11(4):425-33. doi: 10.1016/j.jalz.2014.03.002. Epub 2014 Jun 18.

PMID:
24954370
24.

Cardiovascular consequences of a polygenetic component of blood pressure in an urban-based longitudinal study: the Malmö diet and cancer.

Fava C, Ohlsson T, Sjögren M, Tagetti A, Almgren P, Engström G, Nilsson P, Hedblad B, Minuz P, Melander O.

J Hypertens. 2014 Jul;32(7):1424-8; discussion 1428. doi: 10.1097/HJH.0000000000000209.

PMID:
24879493
25.

Association of BTG2, CYR61, ZFP36, and SCD gene polymorphisms with Graves' disease and ophthalmopathy.

Planck T, Shahida B, Sjögren M, Groop L, Hallengren B, Lantz M.

Thyroid. 2014 Jul;24(7):1156-61. doi: 10.1089/thy.2013.0654. Epub 2014 Jun 3.

26.

Smoking modifies the associated increased risk of future cardiovascular disease by genetic variation on chromosome 9p21.

Hamrefors V, Hedblad B, Hindy G, Smith JG, Almgren P, Engström G, Sjögren M, Gränsbo K, Orho-Melander M, Melander O.

PLoS One. 2014 Jan 22;9(1):e85893. doi: 10.1371/journal.pone.0085893. eCollection 2014.

27.

A randomised trial of the effect of the glycine reuptake inhibitor Org 25935 on cognitive performance in healthy male volunteers.

Christmas D, Diaper A, Wilson S, Rich A, Phillips S, Udo de Haes J, Sjogren M, Nutt D.

Hum Psychopharmacol. 2014 Mar;29(2):163-71.

PMID:
24424780
28.

Developing novel blood-based biomarkers for Alzheimer's disease.

Snyder HM, Carrillo MC, Grodstein F, Henriksen K, Jeromin A, Lovestone S, Mielke MM, O'Bryant S, Sarasa M, Sjøgren M, Soares H, Teeling J, Trushina E, Ward M, West T, Bain LJ, Shineman DW, Weiner M, Fillit HM.

Alzheimers Dement. 2014 Jan;10(1):109-14. doi: 10.1016/j.jalz.2013.10.007. Review.

29.

Genetic variation in NEDD4L, an epithelial sodium channel regulator, is associated with cardiovascular disease and cardiovascular death.

Dahlberg J, Sjögren M, Hedblad B, Engström G, Melander O.

J Hypertens. 2014 Feb;32(2):294-9. doi: 10.1097/HJH.0000000000000044.

PMID:
24284497
30.

Alzheimer biomarkers and clinical Alzheimer disease were not associated with increased cerebrovascular disease in a memory clinic population.

Spies PE, Verbeek MM, Sjogren MJ, de Leeuw FE, Claassen JA.

Curr Alzheimer Res. 2014 Jan;11(1):40-6.

PMID:
24251395
31.

Ceruloplasmin and atrial fibrillation: evidence of causality from a population-based Mendelian randomization study.

Adamsson Eryd S, Sjögren M, Smith JG, Nilsson PM, Melander O, Hedblad B, Engström G.

J Intern Med. 2014 Feb;275(2):164-71. doi: 10.1111/joim.12144. Epub 2013 Oct 23.

32.

The future of blood-based biomarkers for Alzheimer's disease.

Henriksen K, O'Bryant SE, Hampel H, Trojanowski JQ, Montine TJ, Jeromin A, Blennow K, Lönneborg A, Wyss-Coray T, Soares H, Bazenet C, Sjögren M, Hu W, Lovestone S, Karsdal MA, Weiner MW; Blood-Based Biomarker Interest Group.

Alzheimers Dement. 2014 Jan;10(1):115-31. doi: 10.1016/j.jalz.2013.01.013. Epub 2013 Jul 11. Review.

33.

Are 25 SNPs from the CARDIoGRAM study associated with ischaemic stroke?

Lövkvist H, Sjögren M, Höglund P, Engström G, Jern C, Olsson S, Smith JG, Hedblad B, Andsberg G, Delavaran H, Jood K, Kristoffersson U, Norrving B, Melander O, Lindgren A.

Eur J Neurol. 2013 Sep;20(9):1284-91. doi: 10.1111/ene.12183. Epub 2013 Apr 30.

PMID:
23631657
34.

Smoking and obesity associated BDNF gene variance predicts total and cardiovascular mortality in smokers.

Halldén S, Sjögren M, Hedblad B, Engström G, Narkiewicz K, Hoffmann M, Wahlstrand B, Hedner T, Melander O.

Heart. 2013 Jul;99(13):949-53. doi: 10.1136/heartjnl-2013-303634. Epub 2013 Apr 27.

PMID:
23624487
35.

Chromosome 9p21 genetic variation explains 13% of cardiovascular disease incidence but does not improve risk prediction.

Gränsbo K, Almgren P, Sjögren M, Smith JG, Engström G, Hedblad B, Melander O.

J Intern Med. 2013 Sep;274(3):233-40. doi: 10.1111/joim.12063. Epub 2013 Mar 25.

36.

Prediction of mild cognitive impairment that evolves into Alzheimer's disease dementia within two years using a gene expression signature in blood: a pilot study.

Roed L, Grave G, Lindahl T, Rian E, Horndalsveen PO, Lannfelt L, Nilsson C, Swenson F, Lönneborg A, Sharma P, Sjögren M.

J Alzheimers Dis. 2013;35(3):611-21. doi: 10.3233/JAD-122404.

PMID:
23478308
37.

Genetic associations with valvular calcification and aortic stenosis.

Thanassoulis G, Campbell CY, Owens DS, Smith JG, Smith AV, Peloso GM, Kerr KF, Pechlivanis S, Budoff MJ, Harris TB, Malhotra R, O'Brien KD, Kamstrup PR, Nordestgaard BG, Tybjaerg-Hansen A, Allison MA, Aspelund T, Criqui MH, Heckbert SR, Hwang SJ, Liu Y, Sjogren M, van der Pals J, Kälsch H, Mühleisen TW, Nöthen MM, Cupples LA, Caslake M, Di Angelantonio E, Danesh J, Rotter JI, Sigurdsson S, Wong Q, Erbel R, Kathiresan S, Melander O, Gudnason V, O'Donnell CJ, Post WS; CHARGE Extracoronary Calcium Working Group.

N Engl J Med. 2013 Feb 7;368(6):503-12. doi: 10.1056/NEJMoa1109034.

38.

Prediction of blood pressure changes over time and incidence of hypertension by a genetic risk score in Swedes.

Fava C, Sjögren M, Montagnana M, Danese E, Almgren P, Engström G, Nilsson P, Hedblad B, Guidi GC, Minuz P, Melander O.

Hypertension. 2013 Feb;61(2):319-26. doi: 10.1161/HYPERTENSIONAHA.112.202655. Epub 2012 Dec 10. Erratum in: Hypertension. 2013 May;61(5):e50.

PMID:
23232644
39.

Genetic polymorphisms confer risk of atrial fibrillation in patients with heart failure: a population-based study.

Smith JG, Melander O, Sjögren M, Hedblad B, Engström G, Newton-Cheh C, Platonov PG.

Eur J Heart Fail. 2013 Mar;15(3):250-7. doi: 10.1093/eurjhf/hfs176. Epub 2012 Nov 6.

40.

The Renalase Asp37Glu polymorphism is not associated with hypertension and cardiovascular events in an urban-based prospective cohort: the Malmö Diet and cancer study.

Fava C, Montagnana M, Danese E, Sjögren M, Almgren P, Engström G, Hedblad B, Guidi GC, Minuz P, Melander O.

BMC Med Genet. 2012 Jul 19;13:57.

41.

Genetic variation within the interleukin-1 gene cluster and ischemic stroke.

Olsson S, Holmegaard L, Jood K, Sjögren M, Engström G, Lövkvist H, Blomstrand C, Norrving B, Melander O, Lindgren A, Jern C.

Stroke. 2012 Sep;43(9):2278-82. doi: 10.1161/STROKEAHA.111.647446. Epub 2012 Jun 28.

PMID:
22744645
42.

Tailored vs. standardized internet-based cognitive behavior therapy for depression and comorbid symptoms: a randomized controlled trial.

Johansson R, Sjöberg E, Sjögren M, Johnsson E, Carlbring P, Andersson T, Rousseau A, Andersson G.

PLoS One. 2012;7(5):e36905. doi: 10.1371/journal.pone.0036905. Epub 2012 May 15.

43.

Meta-analysis identifies six new susceptibility loci for atrial fibrillation.

Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, Smith AV, Arking DE, Müller-Nurasyid M, Krijthe BP, Lubitz SA, Bis JC, Chung MK, Dörr M, Ozaki K, Roberts JD, Smith JG, Pfeufer A, Sinner MF, Lohman K, Ding J, Smith NL, Smith JD, Rienstra M, Rice KM, Van Wagoner DR, Magnani JW, Wakili R, Clauss S, Rotter JI, Steinbeck G, Launer LJ, Davies RW, Borkovich M, Harris TB, Lin H, Völker U, Völzke H, Milan DJ, Hofman A, Boerwinkle E, Chen LY, Soliman EZ, Voight BF, Li G, Chakravarti A, Kubo M, Tedrow UB, Rose LM, Ridker PM, Conen D, Tsunoda T, Furukawa T, Sotoodehnia N, Xu S, Kamatani N, Levy D, Nakamura Y, Parvez B, Mahida S, Furie KL, Rosand J, Muhammad R, Psaty BM, Meitinger T, Perz S, Wichmann HE, Witteman JC, Kao WH, Kathiresan S, Roden DM, Uitterlinden AG, Rivadeneira F, McKnight B, Sjögren M, Newman AB, Liu Y, Gollob MH, Melander O, Tanaka T, Stricker BH, Felix SB, Alonso A, Darbar D, Barnard J, Chasman DI, Heckbert SR, Benjamin EJ, Gudnason V, Kääb S.

Nat Genet. 2012 Apr 29;44(6):670-5. doi: 10.1038/ng.2261.

44.

Pharmacogenetic implications for eight common blood pressure-associated single-nucleotide polymorphisms.

Hamrefors V, Sjögren M, Almgren P, Wahlstrand B, Kjeldsen S, Hedner T, Melander O.

J Hypertens. 2012 Jun;30(6):1151-60. doi: 10.1097/HJH.0b013e3283536338.

PMID:
22525200
45.

Orthostatic hypotension and novel blood pressure-associated gene variants: Genetics of Postural Hemodynamics (GPH) Consortium.

Fedorowski A, Franceschini N, Brody J, Liu C, Verwoert GC, Boerwinkle E, Couper D, Rice KM, Rotter JI, Mattace-Raso F, Uitterlinden A, Hofman A, Almgren P, Sjögren M, Hedblad B, Larson MG, Newton-Cheh C, Wang TJ, Rose KM, Psaty BM, Levy D, Witteman J, Melander O.

Eur Heart J. 2012 Sep;33(18):2331-41. doi: 10.1093/eurheartj/ehs058. Epub 2012 Apr 14.

46.

The functional variant V433M of the CYP4F2 and the metabolic syndrome in Swedes.

Fava C, Montagnana M, Danese E, Sjögren M, Almgren P, Guidi GC, Hedblad B, Engström G, Minuz P, Melander O.

Prostaglandins Other Lipid Mediat. 2012 May;98(1-2):31-6. doi: 10.1016/j.prostaglandins.2012.03.001. Epub 2012 Mar 30.

PMID:
22484021
47.

Evaluation of the glycine transporter inhibitor Org 25935 as augmentation to cognitive-behavioral therapy for panic disorder: a multicenter, randomized, double-blind, placebo-controlled trial.

Nations KR, Smits JA, Tolin DF, Rothbaum BO, Hofmann SG, Tart CD, Lee A, Schipper J, Sjogren M, Xue D, Szegedi A, Otto MW.

J Clin Psychiatry. 2012 May;73(5):647-53. doi: 10.4088/JCP.11m07081. Epub 2012 Feb 21.

PMID:
22394471
48.

A large-sample assessment of possible association between ischaemic stroke and rs12188950 in the PDE4D gene.

Lövkvist H, Olsson S, Höglund P, Melander O, Jern C, Sjögren M, Engström G, Smith JG, Hedblad B, Andsberg G, Delavaran H, Jood K, Kristoffersson U, Luthman H, Norrving B, Lindgren A.

Eur J Hum Genet. 2012 Jul;20(7):783-9. doi: 10.1038/ejhg.2012.4. Epub 2012 Jan 25.

49.

Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence.

D'Souza DC, Singh N, Elander J, Carbuto M, Pittman B, Udo de Haes J, Sjogren M, Peeters P, Ranganathan M, Schipper J.

Neuropsychopharmacology. 2012 Mar;37(4):1036-46. doi: 10.1038/npp.2011.295. Epub 2011 Nov 23.

50.

A myocardial infarction genetic risk score is associated with markers of carotid atherosclerosis.

Hamrefors V, Hedblad B, Engström G, Almgren P, Sjögren M, Melander O.

J Intern Med. 2012 Mar;271(3):271-81. doi: 10.1111/j.1365-2796.2011.02472.x. Epub 2011 Nov 21.

Supplemental Content

Loading ...
Support Center